MedTrace Logo

Chidamide Combined With Cisplatin in Head and Neck Adenoid Cystic Carcinoma (HNACC)

NCT03639168 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2021-08-19

No results posted yet for this study

Summary

The investigators conducted this study to evaluate the efficacy of Chidamide combined with cisplatin in recurrent or metastatic head and neck adenoid cystic carcinoma.

Conditions

  • Adenoid Cystic Carcinomas
  • Cisplatin

Interventions

DRUG

Chidamide combined with cisplatin

Chidamide combined with cisplatin

Sponsors & Collaborators

  • Fudan University

    lead OTHER

Principal Investigators

  • Kai Xue, MD · Department of medical oncology,Fudan University, Shanghai Cancer Center

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-06-06
Primary Completion
2020-06-24
Completion
2021-06-02

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03639168 on ClinicalTrials.gov